GE HEALTHCARE A/S — Financial report

CVR 70979217

Latest financial period

  • 2025 • 2025-01-01 • 2025-12-31 • entity • SEK • 12937278 • 2345119 • 2031411 • 34835388 • 18456134 • 3

Financial history

  • 2024 • 2024-01-01 • 2024-12-31 • entity • SEK • 11279387 • 2014258 • 2070442 • 28551640 • 16424723 • 3
  • 2023 • 2023-01-01 • 2023-12-31 • entity • DKK • 9360438 • 1468231 • 1389896 • 30790573 • 14354281 • 3
  • 2022 • 2022-01-01 • 2022-12-31 • entity • DKK • 9032842 • 1651469 • 1342346 • 22056974 • 12964385 • 3
  • 2021 • 2021-01-01 • 2021-12-31 • entity • DKK • 9427429 • 1663031 • 1257494 • 54469835 • 46622039 • 3
  • 2020 • 2020-01-01 • 2020-12-31 • entity • DKK • 10646450 • 2103386 • 1531882 • 52360725 • 42101512 • 3
  • 2019 • 2019-01-01 • 2019-12-31 • entity • DKK • 12342330 • 1671419 • 1094907 • 56873128 • 40569630 • 4
  • 2018 • 2018-01-01 • 2018-12-31 • entity • DKK • 12122109 • 1863993 • 1294900 • 58616464 • 39474724 • 4
  • 2017 • 2017-01-01 • 2017-12-31 • entity • DKK • 13699078 • 2170682 • 1133507 • 55269896 • 38179824 • 5

Annual report highlights

  • primary activities • The main activity of the Company is to trade in research- and pharmaceutical products, mainly sales of specialized products for the diagnosis of diseases. These include radiological contrast agents (X-ray / computed tomography or magnetic camera examination), ultrasound contrast agent for cardiology, and radiopharmaceuticals for diagnosis (SPECT, PET) and treatment. The Company is a distributor and part of the Pharmaceutical Diagnostics (PDx) business unit of GE HealthCare Technologies Inc. • entity
  • subsequent events • After the end of the financial year, no events have occurred which may change the financial position of the entity substantially. • entity
  • contingent liabilities • Rental and lease liabilities at 31 December 2025 amounts to TDKK 0 (2024: TDKK 0). GE Healthcare A/S is in the national Danish joint taxation with the other Danish companies in the GEHC group. The company is jointly and severally liable for withholding tax and joint taxation with the other companies in the Danish joint taxation. Possible corrections in the future of the withholding tax might cause that the joint and several liability will change compared to the debt recognized as of 31 December. Pillar II The Company, as the subsidiary of GE HealthCare Technologies Inc., is within the scope of the Organisation for Economic Co-operation and Development (OECD) Pillar Two model rules (“Pillar Two”). The Pillar Two legislation was enacted in Denmark in December 2023, the jurisdiction in which the Company is incorporated. Upon enactment, the Pillar Two taxation regime (specifically the qualifying domestic minimum top-up tax (“QDMTT”)) came into effect on 1 January 2024. The Company has applied the exception to recognizing and disclosing information about deferred tax assets and liabilities related to Pillar Two income taxes, as provided in the Amendments to IAS 12 issued in 2023. The result of the analysis indicated that the Company will qualify for applying the transitional Country-by-Country Reporting (CbCR) safe harbor in 2025 and avoid any incremental tax under the Pillar Two taxation regime, specifically the QDMTT. The Company’s ultimate parent entity is domiciled in the United States. Although the United States has not adopted its respective Pillar Two legislation as of 31 December 2025, no incremental top up tax is expected to arise under any applicable undertaxed profit rule (UTPR) at the level of the intermediary parent. • entity